List of Lansoprazole drug patents

Lansoprazole is owned by Dexcel Pharma.

Lansoprazole contains Lansoprazole.

Lansoprazole has a total of 1 drug patent out of which 0 drug patents have expired.

Lansoprazole was authorised for market use on 07 June, 2016.

Lansoprazole is available in tablet, orally disintegrating, delayed release;oral dosage forms.

The generics of Lansoprazole are possible to be released after 21 April, 2036.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11077055 DEXCEL PHARMA Orally disintegrating compositions
Apr, 2036

(13 years from now)

Drugs and Companies using LANSOPRAZOLE ingredient

Market Authorisation Date: 07 June, 2016

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in